Topical versus systemic tranexamic acid after total knee and hip arthroplasty: A meta-analysis of randomized controlled trials

BACKGROUND: Tranexamic acid (TXA) is an antifibrinolytic drug widely used to reduce blood loss during joint replacements, including total knee arthroplasty (TKA) and total hip arthroplasty (THA). However, there is no final consensus regarding the composition of an optimal administration of TXA regim...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Yongcai, Chen, Zhuo, Cui, Shuo, Li, Zhiyang, Yuan, Zhengjiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2016
Materias:
7000
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5072927/
https://www.ncbi.nlm.nih.gov/pubmed/27741100
http://dx.doi.org/10.1097/MD.0000000000004656

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5072927/
https://www.ncbi.nlm.nih.gov/pubmed/27741100
http://dx.doi.org/10.1097/MD.0000000000004656

Ejemplares similares